DOCSLIB.ORG

Selective Toxicity of Rhodamine 123 in Carcinoma Cells in Vitro

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Selective Toxicity of Rhodamine 123 in Carcinoma Cells in Vitro [CANCER RESEARCH 43, 716-720, February 1983] 0008-5472/83/0043-0000502.00 Selective Toxicity of Rhodamine 123 in Carcinoma Cells in Vitro Theodore J. Lampidis, 1 Samuel D. Bernal, 2 lan C. Summerhayes, and Lan Bo Chen a Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 ABSTRACT ing appears to be unique, since chemotherapeutic agents currently in clinical use have not been shown to be particularly The study of mitochondria in situ has recently been facilitated selective between tumorigenic and normal cells in vitro. through the use of rhodamine 123, a mitochondrial-specific fluorescent dye. It has been found to be nontoxic when applied MATERIALS AND METHODS for short periods to a variety of cell types and has thus become an invaluable tool for examining mitochondrial morphology and Cell Cultures. All cell types and cell lines were grown in Dulbecco's function in the intact living cell. In this report, however, we modified Eagle's medium supplemented with 10% calf serum (M. A. demonstrate that with continuous exposure, rhodamine 123 Bioproducts, Walkersville, Md.) at 37 ~ with 5% CO2. The following cell selectively kills carcinoma as compared to normal epithelial lines were obtained from the American Type Culture Collection: cells grown in vitro. At doses of rhodamine 123 which were CCL 105, CCL 15, CRL 1550, CRL 1420, CCL51, CCL77, CCL185, toxic to carcinoma cells, the conversion of mitochondrial-spe- CCL 34, PtK-1, CV-1, and BSC-I. The human bladder carcinoma line cific to cytoplasmic-nonspecific localization of the drug was (E J) was provided by Dr. L. M. Frank (Imperial Cancer Research Fund). observed prior to cell death. At 10 /~g/ml, >50% cell death EJ and mouse bladder epithelial cells were isolated and grown as described previously (10). MCF-7 was provided by Dr. M. Rich (Mich- occurred within 7 days in all nine of the carcinoma cell types igan Cancer Foundation). Human breast epithelial cells were gifts from and lines of different origin studied, while six of six normal Dr. N. S. Yang (Michigan Cancer Foundation) and Dr. M. Stampfer epithelial cell types and lines remained unaffected. Cotreating (Peralta Cancer Research Institute). carcinoma cells with 2-deoxyglucose and rhodamine 1 23 en- Cytotoxicity and Clonogenic Survival Assays. For the cytotoxicity hanced the inhibition of growth by rhodamine 123 alone in assays, cells were seeded at 5 x 10 ~ cells/60-mm plate and incubated clonogenic survival assays. The observation of the selective at 37 ~ in 5% CO2. Rhodamine 123 (Eastman Kodak, Rochester, N. Y.) toxicity of rhodamine 1 23 appears to be unique in view of the was applied the following day at the indicated doses, and cell numbers absence of selective toxicity reported in vitro for the various were monitored at various periods during continuous drug exposure by antitumor agents currently in clinical use. Preliminary results trypsinizing the appropriate cultures and counting the number of cells with rhodamine 1 23 in animal tumor systems indicate antitumor by hemocytometer. The exclusion of trypan blue (0.2%) was used as an indicator of the number of live cells. For the clonogenic assays, 300 activity for carcinomas. cells were seeded in 60-mm dishes and incubated at 37 ~ in 5% CO2. On the following day, drug was applied at the indicated doses, and INTRODUCTION CFU ~ were determined 2 weeks later by staining with methylene blue (0.2%). Rhodamine 1 23, a cationic fluorescent dye, has been used Fluorescence Localization. Cells were grown on 12-mm round glass previously to specifically localize mitochondria in living cells coverslips (Rochester Scientific, Rochester, N. Y.), treated with rho- (9). It has been a convenient and useful tool for mitochondrial damine 123 for various time periods, and rinsed and mounted on glass studies in situ, since their detectability is enhanced and the dye slides with silicone rubber chambers in rhodamine-free medium as is relatively nontoxic in most of the cell types studied (1-3, 5- described previously (9). Stained cells were examined by epifluores- 9, 1 1, 1 2). Recently, however, rhodamine 1 23 has been found cent illumination at 485 nm on a Zeiss Photomicroscope III equipped with a Zeiss Planapochromat objective lens (x40). to inhibit oxidative phosphorylation in isolated mitochondria at high doses" and has been reported to have a cytostatic effect in L1 21 0 cells (4). Since we had observed that carcinoma cells RESULTS accumulate and retain more rhodamine 123 than do normal Chart 1 illustrates the difference in the effect of rhodamine epithelial cells, fibroblasts, myoblasts, chondrocytes, and lym- 123 on the growth of transformed and normal epithelial cell phocytes (1 1), we were prompted to investigate the cytotoxic lines. Chart 1, A and C, illustrate the marked difference be- effects of this agent on carcinoma cells. In this report, we tween treated and untreated cultures in 2 tumor-derived epi- demonstrate that rhodamine 1 23 selectively inhibits the growth thelial cell lines, human pancreatic carcinoma line CRL 1420 and kills carcinoma-derived epithelial cells in vitro, while the and human breast carcinoma line MCF-7. At 2 days of treat- growth of normal epithelial cells remains unaffected. This find- ment, a marked cytotoxic effect is seen in cell line CRL 1420, 1 Supported by a Young Investigators Award (CA24771). To whom requests while MCF-7 cells are inhibited in their growth. With further for reprints should be addressed, at Sidney Farber Cancer Institute, Harvard incubation, 3 days for CRL 1420 and 7 days for MCF-7, the Medical School, 44 Binney Street, Boston, Mass. 02115. 2 Supported by a Postdoctoral Fellowship (CA06943) from the National Cancer cell number is reduced to less than 103 per plate in each of the Institute. rhodamine-treated cultures. In marked contrast to these re- 3 Recipient of an American Cancer Society Faculty Research Award. Sup- ported by grants from the National Cancer Institute, CA 22427, and the American sults, CV-1 and PtK-1, derived from normal African green Cancer Society, CD 92B. monkey kidney (epithelial) and normal marsupial kidney (epi- "T. J. Lampidis, C. Salet, G. Moreno, and L. B. Chen. Effects of the mito- thelial), respectively, show no cytotoxicity when exposed to the chondrial probe rhodamine 123 and related analogues on the function and viability of pulsating myocardial cells in culture, submitted for publication. Received June 21, 1982; accepted November 5, 1982. The abbreviation used is: CFU, colony-forming units. 716 CANCER RESEARCH VOL. 43 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 1983 American Association for Cancer Research. Rhodamine 123 Kills Carcinoma Cells in vitro same dose of rhodamine 123 (Chart 1, B and D). With even hanced by cotreating with 2-deoxyglucose. longer exposure (2 weeks at 10 #g/ml) or at higher doses (50 To determine whether the selective toxicity of rhodamJne /zg/ml for 7 days), cell growth of CV-1 and PtK-1 remains 123 is a general phenomenon shared by other tumorigenic relatively unaffected. epithelial cells, a number of carcinoma lines were studied. In the course of these experiments, it was noted that a Table 2 is a composite of 15 different cell lines tested for significant number of cells had detached from the culture dish sensitivity to rhodamine 123 when exposed continuously to surface after drug treatment (3 days for CRL 1420 and 7 days various doses. It can be seen that all 9 tumorigenic carcinoma- for MCF-7). We followed the fate of these cells in the presence derived epithelial cell lines used in this study were susceptible of drug with increasing time and found that they converted to the cytotoxic effects of rhodamine 1 23 at 10 or 50/zg/ml. gradually from trypan blue negative to trypan blue positive. In The nontumorigenic epithelial cell lines derived from normal addition, we have tested the ability of these detached cells, tissues were unaffected by treatment at these doses and con- while still trypan-blue negative, to proliferate in drug-free me- tinued to grow normally as untreated cells. Thus, a dose of dium and found that they are no longer able to reattach to the --<10/~g/ml, at which 50% of the treated cells were killed, was culture dish surface nor divide in suspension. found for each of the carcinoma cell lines tested, whereas the The selective toxicity of rhodamine 123 for carcinoma cells dose at which 50% of the treated normal epithelial cell lines was also observed when clonogenic survival assays were per- were killed was >50/zg/ml. To confirm the epithelial origin of formed. Chart 2 illustrates the difference in CFU between the cell lines tested, immunofluorescence staining with keratin rhodamine 1 23-treated normal epithelial (CV-1) and carcinoma antibody was used. All cell lines desiqnated in this report as (1420) cell lines. At 5 /~g/ml, the carcinoma cells form no epithelial or carcinoma were keratin positive. colonies while the normal cells remain relatively unaffected In conjunction with these experiments, each cell line was (CFU are 83% of control). Thus, although there is a slight tested for its sensitivity to the potent, broad-spectrum antitumor reduction in normal colony formation, the same pattern of agent Adriamycin. Although some of the carcinoma cell lines carcinoma sensitivity versus normal cell resistance to rhoda- did appear to be more sensitive to Adriamycin than did the mine 1 23 treatment as seen in the growth experiments prevails. untransformed lines, the complete insensitivity of normal epi- Since rhodamine 123 inhibits oxidative phosphorylation in thelial cells to rhodamine 1 23 at high doses (50 #g/ml) and for isolated mitochondria, 4 we were interested in testing whether prolonged exposure times (7 days) suggests a stronger selec- an inhibitor of glycolysis, 2-deoxyglucose, could affect the selective toxicity of rhodamine 123 for carcinoma cells.
Load more

Recommended publications
  • Increased Mitochondrial Uptake of Rhodamine 123 During Lymphocyte Stimulation
    Proc. Natl. Acad. Sci. USA Vol. 78, No. 4, pp. 2383-2387, April 1981 Cell Biology Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation (flow cytometry/cycling-noncycling cells/supravital fluorescent probe) ZBIGNIEW DARZYNKIEWICZ, LISA STAIANO-COICO, AND MYRON R. MELAMED Memorial Sloan-Kettering Cancer Center, New York, New York 10021 Communicated by Lloyd J. Old, January 5, 1981 ABSTRACT The positively charged rhodamine analog rho- trifugation on Ficoll/Isopaque (Lymphoprep; Nyegaardo, Oslo, damine 123 accumulates specifically in the mitochondria of living Norway). The mononuclear cells were suspended in Eagle's cells. In the present work, the uptake of rhodamine 123 by indi- basal medium containing 15% fetal bovine serum and subcul- vidual lymphocytes undergoing blastogenic transformation in cul- tured in plastic dishes to remove most ofthe monocytes (3). The tures stimulated by phytohemagglutinin was measured by flow nonadhering cells were then suspended in Eagle's medium con- cytometry. A severalfold increase in cell ability to accumulate rho- taining penicillin, streptomycin, and 15% fetal bovine serum damine 123 was observed during lymphocyte stimulation. Maxi- and incubated at 37°C in the presence of PHA (phytohemag- mal dye uptake, seen on the third day ofcell stimulation, coincided glutinin M, GIBCO) as described (2, 3). The samples were with- in time with the peak of DNA synthesis (maximal number of cells drawn from these cultures at daily intervals. Other details ofthe in the S phase) and mitotic activity. A large intercellular variation are elsewhere 3). among stimulated lymphocytes, with some cells having fluores- cell culture system given (2, cence increased as much as 15 times in comparison with nonstim- Cell Staining.
    [Show full text]
  • Reversal of Resistance to Rhodamine 123 in Adriamycin-Resistant Friend Leukemia Cells1
    [CANCER RESEARCH 45, 2626-2631, June 1985] Reversal of Resistance to Rhodamine 123 in Adriamycin-resistant Friend Leukemia Cells1 Theodore J. Lampidis,2 Jean-Nicolas Munck, Awtar Krishan, and Haim Tapiero Department of Oncology, University of Miami, School of Medicine, Comprehensive Cancer Center for the State of Florida, Miami, Florida 33101 [T. J. L, A. K.], and Departement de Pharmacologie Cellulaire, Moléculaireet de Pharmacocinétique, ICIG (CNRS LA-149), Hôpital Paul-Brousse, 94804 Villejuif, France [J-N. M., H. T.] ABSTRACT the calcium transport inhibitor, verapamil, on the cellular accu mulation and retention of Rho-123 and ADM as it relates to Pleiotropic resistance to rhodamine 123 (Rho-123) in Adria- resistance in these cell variants. mycin (ADM)-resistant Friend leukemia cells was circumvented by cotreatment with 10 //M verapamil. Increased cytotoxicity corresponded to higher intracellular Rho-123 levels. The vera- MATERIALS AND METHODS pamil-induced increase of drug accumulation in resistant cells is Cells and Cytotoxicity Assay. FLC were derived from a clone of accounted for at least in part by the blockage or slowing of Rho- Friend virus-tranformed 745A cells. Cells were seeded and grown as 123 efflux from these cells. In contrast, accumulation and con described previously (8). The cell variant resistant to ADM (ADM-RFLC3) sequent cytotoxicity of Rho-123 in sensitive cells are not in was derived from the above clone by continuous exposure to ADM (8). creased by verapamil. Similar results were obtained when ADM Resistant cells, grown for more than 150 passages in drug-free medium, was used in this cell system.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7476,504 B2 Turner (45) Date of Patent: Jan
    USOO7476504B2 (12) United States Patent (10) Patent No.: US 7476,504 B2 Turner (45) Date of Patent: Jan. 13, 2009 (54) USE OF REVERSIBLE EXTENSION Glatthar, Ralf, et al. 2000. A New Photocleavable Linker in Solid TERMINATOR IN NUCLECACD Phase Chemistry for Ether Cleavage. Org. Lett. 2(15): 2315-2317. SEQUENCING Goldmacher, Victor S., et al. 1992. Photoactivation of Toxin Conju gates. Bioconjugate Chem. 3(2): 104-107. Guillier, Fabrice, et al. 2000. Linkers and Cleavage Strategies in (75) Inventor: Stephen Turner, Menlo Park, CA (US) Solid-Phase Organic Synthesis and Combinatorial Chemistry. Chem. Rev. 100(6): 2091-2157. (73) Assignee: Pacific Biosciences of California, Inc., Holmes, Christopher P. 1997. Model Studies for New o-Nitrobenzyl Menlo Park, CA (US) Photolabile Linkers: Substituent Effects on the Rates of Photochemi cal Cleavage.J. Org. Chem. 62(8): 2370-2380. (*) Notice: Subject to any disclaimer, the term of this Hu, Jun, et al. 2001. Competitive Photochemical Reactivity in a patent is extended or adjusted under 35 Self-Assembled Monolayer on a Colloidal Gold Cluster. J. Am. U.S.C. 154(b) by 365 days. Chem. Soc. 123(7): 1464-1470. Kessler, Martin, et al. 2003. Sequentially Photocleavable Protecting (21) Appl. No.: 11/341,041 Groups in Solid-Phase Synthesis. Org. Lett.5(8); 1179-1181. Kim, Hanyoung, et al. 2004. Core-Shell-Type Resins for Solid-Phase (22) Filed: Jan. 27, 2006 Peptide Synthesis: Comparison with Gel-Type Resins in Solid-Phase Photolytic Cleavage Reaction. Org. Lett. 6(19): 3273-3276. (65) Prior Publication Data Maxam, Allan M., et al. 1977. A new method for sequencing DNA.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • L-Cycloserine Amplifies Anti-Tumor Activity of Glutamine Antagonist
    J. Clin. Biochem. Nutr., 14, 53-60, 1993 L-Cycloserine Amplifies Anti-Tumor Activity of Glutamine Antagonist Akira OKADA, Hiroo TAKEHARA, Kanehiro YOSHIDA, Masaharu NISHI, Hidenori MIYAKE, and Nobuhiko KOMI* The First Department of Surgery, School of Medicine, The University of Tokushima, Tokushima 770, Japan (Received September 22, 1992) Summary We examined the effect of simultaneous treatment with 6-diazo-5-oxo-L-norleucine (DON), a glutamine antagonist, and L- cycloserine, a transaminase inhibitor, on Yoshida sarcoma-bearing rats, with the aim of achieving inhibition of both glutamine catabolism and glutamate synthesis. L-Cycloserine, in a dosage of 1-30 mg/kg, was intraperitoneally administered to Yoshida sarcoma-bearing rats, but the administration of L-cycloserine alone did not show any significant effect on the tumor weight. However, combined treatment with DON (1 mg/kg) caused a dose-dependent reduction in the tumor weight. Amino acid analysis of the tumor tissue, performed 24 h after these treatments in order to confirm their influences on amino acid metabolism in the tumor, showed that the increased glutamate level seen after treatment with DON in a previous study was suppressed by simultaneous administration of DON and 10 mg/kg of L-cycloserine. These results suggest that pooled glutamate in the tumor tissue plays some role in resistance to the tumor- reducing activity of this glutamine antagonist. This, in turn, suggests that concurrent inhibition of glutamate production and blockage of glutamine utilization might result in enhanced tumor reduction in a clinical study. Key Words: glutamine antagonist, transaminase inhibitor, glutamate, Yoshida sarcoma, tumor reduction The glutamine antagonist 6-diazo-5-oxo-L-norleucine (DON) evoked tumor reduction in experimental tumors [1-3], but it did not show adequate efficacy in clinical studies [4, 5].
    [Show full text]
  • Mediated Multidrug Resistance (MDR) in Cancer
    A Thesis Entitled: Differential Effects of Dopamine D3 Receptor Antagonists in Modulating ABCG2 - Mediated Multidrug Resistance (MDR) in Cancer by Noor A. Hussein Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science in Pharmaceutical Sciences Degree in Pharmacology and Toxicology _________________________________________ Dr. Amit K. Tiwari, Committee Chair _________________________________________ Dr. Frank Hall , Committee Member _________________________________________ Dr. Zahoor Shah, Committee Member _________________________________________ Dr. Caren Steinmiller, Committee Member _________________________________________ Dr. Amanda Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo May 2017 Copyright 2017, Noor A. Hussein This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Differential Effects of Dopamine D3 Receptor Antagonists in Modulating ABCG2 - Mediated Multidrug Resistance (MDR) by Noor A. Hussein Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science in Pharmaceutical Sciences Degree in Pharmacology and Toxicology The University of Toledo May 2017 The G2 subfamily of the ATP-binding cassette transporters (ABCG2), also known as the breast cancer resistance protein (BRCP), is an efflux transporter that plays an important role in protecting the cells against endogenous and exogenous toxic substances. The ABCG2 transporters are also highly expressed in the blood brain barrier (BBB), providing protection against specific toxic compounds. Unfortunately, their overexpression in cancer cells results in the development of multi-drug resistance (MDR), and thus, chemotherapy failure. Dopamine3 receptor (D3R) antagonists were shown to have excellent anti-addiction properties in preclinical animal models but produced limited clinical success with the lead molecule.
    [Show full text]
  • Biological Stains & Dyes
    BIOLOGICAL STAINS & DYES Developed for Biology, microbiology & industrial applications ACRIFLAVIN ALCIAN BLUE 8GX ACRIDINE ORANGE ALIZARINE CYANINE GREEN ANILINE BLUE (SPIRIT SOLUBLE) www.lobachemie.com BIOLOGICAL STAINS & DYES Staining is an important technique used in microscopy to enhance contrast in the microscopic image. Stains and dyes are frequently used in biology and medicine to highlight structures in biological tissues. Loba Chemie offers comprehensive range of Stains and dyes, which are frequently used in Microbiology, Hematology, Histology, Cytology, Protein and DNA Staining after Electrophoresis and Fluorescence Microscopy etc. Many of our stains and dyes have specifications complying certified grade of Biological Stain Commission, and suitable for biological research. Stringent testing on all batches is performed to ensure consistency and satisfy necessary specification particularly in challenging work such as histology and molecular biology. Stains and dyes offer by Loba chemie includes Dry – powder form Stains and dyes as well as wet - ready to use solutions. Features: • Ideally suited to molecular biology or microbiology applications • Available in a wide range of innovative chemical packaging options. Range of Biological Stains & Dyes Product Code Product Name C.I. No CAS No 00590 ACRIDINE ORANGE 46005 10127-02-3 00600 ACRIFLAVIN 46000 8063-24-9 00830 ALCIAN BLUE 8GX 74240 33864-99-2 00840 ALIZARINE AR 58000 72-48-0 00852 ALIZARINE CYANINE GREEN 61570 4403-90-1 00980 AMARANTH 16185 915-67-3 01010 AMIDO BLACK 10B 20470
    [Show full text]
  • Use of the Laser Dye Rhodamine 123
    Status of Mitochondria in Living Human Fibroblasts during Growth and Senescence in Vitro : Use of the Laser Dye Rhodamine 123 SAMUEL GOLDSTEIN and LOUISE B . KORCZACK Departments of Medicine and Biochemistry, McMaster University Medical Center, Hamilton, Ontario, Canada L8N 3Z5. Dr. Goldstein's present address is : Departments of Medicine and Biochemistry, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 Downloaded from ABSTRACT Rhodamine 123, a fluorescent laser dye that is selectively taken up into mitochondria of living cells, was used to examine mitochondrial morphology in early-passage (young), late- passage (old), and progeric human fibroblasts . Mitochondria were readily visualized in all cell types during growth (mid-log) and confluent stages . In all cell strains at confluence, mitochon- jcb.rupress.org dria became shorter, more randomly aligned, and developed a higher proportion of bead-like forms . Treatment of cells for six days with Tevenel, a chloramphenicol analog that inhibits mitochondrial protein synthesis, brought about a marked depletion of mitochondria and a diffuse background fluorescence . Cyanide produced a rapid release of preloaded mitochondria) fluorescence followed by detachment and killing of cells . Colcemid caused a random coiling on January 8, 2018 and fragmentation of mitochondria particularly in the confluent stage . No gross differences were discernible in mitochondria of the three cell strains in mid-log and confluent states or after these treatments . Butanol-extractable fluorescence after loading with rhodamine 123 was lower in all cell strains in confluent compared to mid-log stages . At confluence all three cell strains had similar rhodamine contents at zero-time and after washout up to 24 h .
    [Show full text]
  • Cycloserine and Threo-Dihydrosphingosine Inhibit TNF-A-Induced Cytotoxicity: Evidence for the Importance of De Novo Ceramide Synthesis in TNF-A Signaling
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1643 (2003) 1–4 www.bba-direct.com Rapid report Cycloserine and threo-dihydrosphingosine inhibit TNF-a-induced cytotoxicity: evidence for the importance of de novo ceramide synthesis in TNF-a signaling Sybille G. E. Meyer*, Herbert de Groot Institut fu¨r Physiologische Chemie, Universita¨tsklinikum Essen, Hufelandstrasse 55, D-45147 Essen, Germany Received 2 July 2003; accepted 9 October 2003 Abstract Measuring the cell death induced by tumor necrosis factor (TNF-a) in L929 cells, we discovered for the first time that L-cycloserine, an established inhibitor of serine palmitoyltransferase, as well as DL-threo-dihydrosphingosine (threo-DHS, threo-sphinganine) significantly protected against TNF-a-induced cytotoxicity. Under the same conditions sphingosine and DL-erythro-dihydrosphingosine (erythro-DHS) did not change TNF-a-induced cytotoxicity, thus underlining the specificity of threo-DHS. In serine-labeled cells, newly (de novo) synthetized labeled ceramide was significantly diminished by threo-DHS alone or together with TNF-a, which makes the (dihydro) ceramide synthase the likely target of threo-DHS. These results suggest the decisive role of ceramide de novo synthesis in TNF signaling. D 2003 Elsevier B.V. All rights reserved. Keywords: Ceramide de novo synthesis; Safingol; Sphinganine; Sphingosine; Threo-dihydrosphingosine; Tumor necrosis factor-a (TNF-a) Tumor necrosis factor-a (TNF-a) is a pleiotropic cyto- ceramide was only shown in TNF/cycloheximide-induced kine produced mainly by macrophages. It mediates inflam- cell death in cerebral endothelial cells using Fumonisin B1 mation and regulates immune function by triggering the [9].
    [Show full text]
  • The Antiviral Effect of Epigallocatechin Gallate-Stearate on Enterovirus-69" (2017)
    Montclair State University Montclair State University Digital Commons Theses, Dissertations and Culminating Projects 8-2017 The Antiviral Effect of Epigallocatechin Gallate- Stearate on Enterovirus-69 Hager Mohamed Montclair State University Follow this and additional works at: https://digitalcommons.montclair.edu/etd Part of the Biology Commons Recommended Citation Mohamed, Hager, "The Antiviral Effect of Epigallocatechin Gallate-Stearate on Enterovirus-69" (2017). Theses, Dissertations and Culminating Projects. 16. https://digitalcommons.montclair.edu/etd/16 This Thesis is brought to you for free and open access by Montclair State University Digital Commons. It has been accepted for inclusion in Theses, Dissertations and Culminating Projects by an authorized administrator of Montclair State University Digital Commons. For more information, please contact [email protected]. Abstract Enteroviruses are single stranded RNA viruses responsible for diseases from respiratory illness to hand-foot-and-mouth disease. As a rapidly evolving group, enteroviruses often gain genetic variability which leads to emergence of additional types, one of which is Enterovirus 69 (EV-69). EV-69 has been associated with respiratory illness, possibly causing symptoms similar to those caused by EV-68. To challenge the ability of the virus to infect cells, this study examined the result of infection in lung cell lines A549 and MRC-5 in response to Epigallocatechin gallate-stearate (EGCG-S) treatment of the virus before infection. EGCG-S, a modified green tea polyphenol, was assessed for its efficacy against EV-69 through examination of changes in cell viability, cytopathic effects, cell proliferation, and reactive oxygen species levels. Apoptosis in treated versus untreated virus infected controls was also assessed.
    [Show full text]
  • Antioxidants
    antioxidants Article Insulin–Mimetic Dihydroxanthyletin-Type Coumarins from Angelica decursiva with Protein Tyrosine Phosphatase 1B and α-Glucosidase Inhibitory Activities and Docking Studies of Their Molecular Mechanisms Md Yousof Ali 1 , Susoma Jannat 2, Hyun Ah Jung 3,* and Jae Sue Choi 4,* 1 Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; [email protected] 2 Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada; [email protected] 3 Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Korea 4 Department of Food and Life Science, Pukyong National University, Busan 48513, Korea * Correspondence: [email protected] (H.A.J.); [email protected] (J.S.C.); Tel.: +82-63-270-4882 (H.A.J.); +82-51-629-7547 (J.S.C.) Abstract: As a traditional medicine, Angelica decursiva has been used for the treatment of many dis- eases. The goal of this study was to evaluate the potential of four natural major dihydroxanthyletin- type coumarins—(+)-trans-decursidinol, Pd-C-I, Pd-C-II, and Pd-C-III—to inhibit the enzymes, Citation: Ali, M.Y.; Jannat, S.; Jung, protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase. In the kinetic study of the PTP1B H.A.; Choi, J.S. Insulin–Mimetic enzyme’s inhibition, we found that (+)-trans-decursidinol, Pd-C-I, and Pd-C-II led to competitive Dihydroxanthyletin-Type Coumarins inhibition, while Pd-C-III displayed mixed-type inhibition. Moreover, (+)-trans-decursidinol exhib- from Angelica decursiva with Protein ited competitive-type, and Pd-C-I and Pd-C-II mixed-type, while Pd-C-III showed non-competitive Tyrosine Phosphatase 1B and type inhibition of α-glucosidase.
    [Show full text]
  • PINK1-Dependent Mitophagy Is Driven by the UPS and Can Occur Independently of LC3 Conversion
    Cell Death & Differentiation https://doi.org/10.1038/s41418-018-0219-z ARTICLE PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion 1 1 1,2 1 1 Aleksandar Rakovic ● Jonathan Ziegler ● Christoph U. Mårtensson ● Jannik Prasuhn ● Katharina Shurkewitsch ● 3 4 1 Peter König ● Henry L. Paulson ● Christine Klein Received: 1 February 2017 / Revised: 17 September 2018 / Accepted: 2 October 2018 © The Author(s) 2018 Abstract The Parkinson’s disease (PD)-related ubiquitin ligase Parkin and mitochondrial kinase PINK1 function together in the clearance of damaged mitochondria. Upon mitochondrial depolarization, Parkin translocates to mitochondria in a PINK1-dependent manner to ubiquitinate outer mitochondrial membrane proteins. According to the current model, the ubiquitin- and LC3-binding adaptor protein SQSTM1 is recruited to mitochondria, followed by their selective degradation through autophagy (mitophagy). However, the role of the ubiquitin proteasome system (UPS), although essential for this process, still remains largely elusive. Here, we investigated the role of the UPS and autophagy by applying the potassium fi fi 1234567890();,: 1234567890();,: ionophore Valinomycin in PINK1-de cient human broblasts and isogenic neuroblastoma cell lines generated by CRISPR/ Cas9. Although identical to the commonly used CCCP/FCCP in terms of dissipating the mitochondrial membrane potential and triggering complete removal of mitochondria, Valinomycin did not induce conversion of LC3 to its autophagy-related form. Moreover, FCCP-induced conversion of LC3 occurred even in mitophagy-incompetent, PINK1-deficient cell lines. While both stressors required a functional UPS, the removal of depolarized mitochondria persisted in cells depleted of LC3A and LC3B. Our study highlights the importance of the UPS in PINK1-/Parkin-mediated mitochondrial quality control.
    [Show full text]